InhaleRx (ASX:IRX) Ending Cash Position : A$0.53 Mil (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is InhaleRx Ending Cash Position?

InhaleRx's Ending Cash Position for the quarter that ended in Jun. 2023 was A$0.53 Mil.

InhaleRx's quarterly Ending Cash Position increased from Jun. 2022 (A$1.89 Mil) to Dec. 2022 (A$2.13 Mil) but then declined from Dec. 2022 (A$2.13 Mil) to Jun. 2023 (A$0.53 Mil).

InhaleRx's annual Ending Cash Position declined from Dec. 2021 (A$2.80 Mil) to Dec. 2022 (A$2.13 Mil) and declined from Dec. 2022 (A$2.13 Mil) to Dec. 2023 (A$0.72 Mil).

InhaleRx Ending Cash Position Historical Data

The historical data trend for InhaleRx's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InhaleRx Ending Cash Position Chart

InhaleRx Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

0.43

1.72

2.80

2.13

0.72

InhaleRx Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial									2.80	1.89	2.13	0.53	0.72

InhaleRx Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

InhaleRx's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.134	+	-1.418
	=	0.72

InhaleRx's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.134	+	-1.608
	=	0.53

InhaleRx Ending Cash Position Related Terms

Thank you for viewing the detailed overview of InhaleRx's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx (ASX:IRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.inhalerx.com.au

InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines